REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
8,074,442
Share change
+962,631
Total reported value
$5,649,600
Price per share
$0.70
Number of holders
36
Value change
+$675,094
Number of buys
11
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q4 2014

As of 31 Dec 2014, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,074,442 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, KCG Holdings, Inc., WELLS FARGO & COMPANY/MN, MORGAN STANLEY, NORTHERN TRUST CORP, AQR CAPITAL MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, and Northeast Financial Consultants Inc. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.